Article

Pilot study on the use of low molecular weight heparins in the prevention of thromboembolic disease during pregnancy and puerperium

2022-04-28

Abstract excerpt

A pregnant woman is 4 to 5 times more likely to suffer a thromboembolic event than a non-pregnant woman. Furthermore, an increase in these episodes has been observed in women infected with SARS-CoV-2 . Consequently, the prophylactic prescription of low-molecular-weight heparins (LMWH) in pregnant women is undergoing an increase that has not been evaluated yet. The aim of this study was to determine the prevalence...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: d728868e-9191-5e05-8ce8-eca46435641b
DOI: 10.1101/2022.04.26.22274264

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Pilot study on the use of low molecular weight heparins in the prevention of thromboembolic disease during pregnancy and puerperiumDOI 10.1101/2022.04.26.22274264Read

Pregnancy and COVID ‐19: pharmacologic considerationsSemantic proximity Read

Obstetric complications and pregnancy-related venous thromboembolism: the effect of low-molecular-weight heparin on their prevention in carriers of factor V Leiden or prothrombin G20210A mutation.Semantic proximity Read

Study on the value of thromboelastography in the assessment of thrombosis risk in perinatal womenSemantic proximity Read

Low molecular weight heparin for the prevention of severe preeclampsia: where next?Semantic proximity Read

Diagnostic Value of D-Dimer Concentration for Pregnancy-related Venous Thromboembolism: A Retrospective StudySemantic proximity Read

Aspirin therapy is associated with a lower risk of pregnancy loss in both JAK2- and CALR-mutated essential thrombocythemia-A Mayo Clinic study of 200 pregnancies.Semantic proximity Read

Thromboembolic disease in pregnancy.Semantic proximity Read

Low-dose Aspirin Delays the Onset of Pre-eclampsia in an Unselected Population of Ivf/icsi Pregnancies by Almost 4 WeeksSemantic proximity Read

Is low dose Tranexamic acid less effective than a standard dose at reducing blood loss and inhibiting hyperfibrinolysis in hemorrhagic caesarean section? Multicenter double–blind placebo-controlled dose-ranging (TRACES) trial.Semantic proximity Read

Pregnancy-Associated Extracorporeal Membrane Oxygenation in the United StatesSemantic proximity Read

Circulating maternal placental growth factor responses to low-molecular-weight heparin in pregnant patients at risk of placental dysfunctionSemantic proximity Read

Enoxaparin for thromboprophylaxis in hospitalized COVID-19 patients: comparison of 40 mg o.d.<i>vs</i>40 mg b.i.d. The X-COVID19 Randomized Clinical TrialSemantic proximity Read